RHUMBLINE ADVISERS - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 73 filers reported holding ANTHERA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$22,000
-87.7%
34,480
-39.2%
0.00%
Q3 2016$179,000
+2.9%
56,699
+0.5%
0.00%
-100.0%
Q2 2016$174,000
+26.1%
56,389
+47.4%
0.00%
Q1 2016$138,000
-22.0%
38,254
+0.3%
0.00%
-100.0%
Q4 2015$177,000
-15.7%
38,154
+10.6%
0.00%0.0%
Q3 2015$210,000
-20.5%
34,499
+12.5%
0.00%0.0%
Q2 2015$264,00030,6700.00%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,431,196$2,748,0001.18%
Abingworth LLP 437,994$832,0000.50%
Broadfin Capital, LLC 1,301,622$2,499,0000.26%
Rhenman & Partners Asset Management AB 400,000$768,0000.22%
BVF INC/IL 559,624$1,074,0000.22%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,691,857$3,248,0000.12%
Perceptive Advisors 478,456$919,0000.10%
Gruss Capital Management LP 1,720,000$3,302,0000.08%
SECTORAL ASSET MANAGEMENT INC 247,961$476,0000.02%
Spark Investment Management LLC 36,400$69,0000.01%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders